The Integrin Binding Peptide, ATN-161, as a Novel Therapy for SARS-CoV-2 Infection
Brandon J. Beddingfield(Tulane University), Gregory Bix(Tulane University), Prem P. Chapagain(Florida International University), Naoki Iwanaga(Nagasaki University Hospital), Chad J. Roy(Tulane University), Ye Hu(Arizona State University), Wenshu Zheng(Southern University of Science and Technology), Jay K. Kolls(Tulane University)
Cited by 89
Related Papers
Ectopic colonization of oral bacteria in the intestine drives T <sub>H</sub> 1 cell induction and inflammation
|Science|2017|952
Exogenous administration of heme oxygenase-1 by gene transfer provides protection against hyperoxia-induced lung injury
|Journal of Clinical Investigation|1999|496
Upregulation of heme oxygenase-1 protects genetically fat Zucker rat livers from ischemia/reperfusion injury
|Journal of Clinical Investigation|1999|480
Th17 cells at the crossroads of innate and adaptive immunity against infectious diseases at the mucosa
|Mucosal Immunology|2009|471